(Q39900624)

English

Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Gianluigi Giannelli

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Emilia Fransvea

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Antonio Mazzocca

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Salvatore Antonaci

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

1 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

839-850

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

The specificities of protein kinase inhibitors: an update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Biology of transforming growth factor beta in hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Epithelial-mesenchymal transitions in tumour progression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Disregulation of E-cadherin in transgenic mouse models of liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

Altered localization and cytoplasmic domain-binding properties of tyrosine-phosphorylated beta 1 integrin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

21 January 2018

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative predictors of vascular invasion in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrinogen is a ligand for integrin alpha5beta1 on endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of transforming growth factor-beta 1 in the urine of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

alpha6beta1 integrin expression in hepatocarcinoma cells: regulation and role in cell adhesion and migration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22731

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.22731

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39900624&oldid=2092363118"